By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Canopus BioPharma Incorporated

Canopus BioPharma Incorporated (CBIA)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 22 Aug 2025, 20:00
$455.07K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

CBIA Stock Price Chart

Explore Canopus BioPharma Incorporated interactive price chart. Choose custom timeframes to analyze CBIA price movements and trends.

CBIA Company Profile

Discover essential business fundamentals and corporate details for Canopus BioPharma Incorporated (CBIA) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Shell Companies

IPO Date

31 Dec 1999

Employees

CEO

Patrick T. Prendergast

Description

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.

CBIA Financial Timeline

Browse a chronological timeline of Canopus BioPharma Incorporated corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

CBIA Stock Performance

Access detailed CBIA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run